Ann: Agreement Signed for Sale of Lyramid Limited, page-24

ASX ANNOUNCEMENT MEDICAL THERAPIES SIGNS AGREEMENT FOR THE ACQUISITION OF PLATFORM TECHNOLOGY 16 April 2008, Sydney, Australia:

Medical Therapies Limited (ASX: MTY), announced today that it has entered into an Intellectual Property Agreement with Cell Signals Inc, covering the acquisition of a large portfolio of assets relating to the use of midkine in therapeutic and diagnostic applications.

The intellectual property acquired by Medical Therapies includes 28 patents and patent applications for the diagnosis and treatment of tumors, inflammatory disorders and auto-immune diseases as well as a portfolio of over 120 anti-midkine antibodies.

Consideration for the acquisition involves the issuing of 20 million Medical Therapies shares and $1.5 million cash on settlement to Cell Signals. The transaction is subject to shareholders’ approval. Commenting on the announcement Medical Therapies CEO, Maria Halasz said: “This acquisition adds immediate and significant value to Medical Therapies’ asset portfolio.


lol
13 years later